文献速递消化内镜消化道肿瘤与早癌

COVID-19大流行对英国内镜活动及癌症检出的影响:国家内镜数据库分析

Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis.
PubMed 文献 · Gut · 2020-07-20

基于英国国家内镜数据库(NED)分析COVID-19大流行对内镜服务及内镜癌症诊断的影响。疫情冲击期(2020年3月23日至5月31日)内镜活动降至疫情前水平的12%,最低点仅5%,虽单次操作癌症检出率从1.91%升至6.61%(p<0.001),但每周检出癌症数量下降58%,漏诊癌症比例从19%(胰胆管)至72%(结直肠)。

要点

  • 疫情冲击期内镜活动降至疫情前12%,最低点仅5%,研究结束时恢复至20%。
  • 单次操作癌症检出率疫情前1.91% vs 疫情冲击期6.61%(p<0.001)。
  • 每周检出癌症数量下降58%,漏诊癌症比例19%(胰胆管)至72%(结直肠)。

核心结论

  • 这项国家分析显示大流行对内镜服务造成显著影响,导致癌症检出大幅且令人担忧的下降。
  • 原文结论指出需要进行重大、紧急的努力来恢复内镜能力,以防止迫在眉睫的癌症医疗危机。

研究设计与样本

  • 利用英国国家内镜数据库(NED)开发COVID-19模块,纳入所有内镜操作的操作层面数据。
  • 设定三个时期:疫情前(2020年1月6日至3月15日)、过渡期(3月16日至22日)和疫情冲击期(3月23日至5月31日)。
  • 进行国家、区域和操作特异性分析,计算每周平均癌症数量、漏诊癌症比例和癌症检出率。

主要发现

  • 疫情前每周平均进行35 478例内镜操作。
  • 疫情冲击期内镜活动降至疫情前水平的12%,最低点仅5%,研究结束时恢复至疫情前活动的20%。
  • 更具选择性的审核显著提高单次操作癌症检出率:疫情前1.91% vs 疫情冲击期6.61%(p<0.001)。
  • 每周检出癌症数量下降58%。
  • 漏诊癌症比例范围为19%(胰胆管)至72%(结直肠)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The COVID-19 pandemic has had a major global impact on endoscopic services. This reduced capacity, along with public reluctance to undergo endoscopy during the pandemic, might result in excess mortality from delayed cancer diagnosis. Using the UK's National Endoscopy Database (NED), we performed the first national analysis of the impact of the pandemic on endoscopy services and endoscopic cancer diagnosis. DESIGN: We developed a NED COVID-19 module incorporating procedure-level data on all endoscopic procedures. Three periods were designated: pre-COVID (6 January 2020 to 15 March), transition (16-22 March) and COVID-impacted (23 March-31 May). National, regional and procedure-specific analyses were performed. The average weekly number of cancers, proportion of missing cancers and cancer detection rates were calculated. RESULTS: A weekly average of 35 478 endoscopy procedures were performed in the pre-COVID period. Activity in the COVID-impacted period reduced to 12% of pre-COVID levels; at its low point, activity was only 5%, recovering to 20% of pre-COVID activity by study end. Although more selective vetting significantly increased the per-procedure cancer detection rate (pre-COVID 1.91%; COVID-impacted 6.61%; p<0.001), the weekly number of cancers detected decreased by 58%. The proportion of missing cancers ranged from 19% (pancreatobiliary) to 72% (colorectal). CONCLUSION: This national analysis demonstrates the remarkable impact that the pandemic has had on endoscopic services, which has resulted in a substantial and concerning reduction in cancer detection. Major, urgent efforts are required to restore endoscopy capacity to prevent an impending cancer healthcare crisis.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Rutter MD, Brookes M, Lee TJ, et al. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis. Gut. 2020. PMID: 32690602. doi:10.1136/gutjnl-2020-322179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。